CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LENZ Therapeutics, Inc.
Sign in to watch- Ticker
- LENZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844867570
- Phone
- 858-925-7000
- Business address
- 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
- Former names
- Graphite Bio, Inc.
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Exit or restructuring costs · Executive or director change · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
Page 13 of 18 · 359 filings